International Journal of Biological Macromolecules, Год журнала: 2025, Номер 294, С. 139114 - 139114
Опубликована: Янв. 2, 2025
Язык: Английский
International Journal of Biological Macromolecules, Год журнала: 2025, Номер 294, С. 139114 - 139114
Опубликована: Янв. 2, 2025
Язык: Английский
ACS Nano, Год журнала: 2023, Номер 18(1), С. 229 - 244
Опубликована: Дек. 19, 2023
Colonic epithelial damage and dysregulated immune response are crucial factors in the progression exacerbation of inflammatory bowel disease (IBD). Nanoenabled targeted drug delivery to inflamed intestinal mucosa has shown promise inducing maintaining colitis remission, while minimizing side effects. Inspired by excellent antioxidative anti-inflammatory efficacy naturally derived magnolol (Mag) gut homeostasis regulation microbiota-derived butyrate, we developed a pH/redox dual-responsive butyrate-rich polymer nanoparticle (PSBA) as an oral Mag system for combinational therapy IBD. PSBA showed high butyrate content 22% effectively encapsulated Mag. The Mag-loaded nanoparticles (PSBA@Mag) demonstrated colonic pH reduction-responsive release, ensuring efficient retention adhesion colon mice. PSBA@Mag not only normalized level reactive oxygen species effectors but also restored barrier function both ulcerative Crohn's mouse models. Importantly, promoted migration healing ability cells vitro vivo, sensitizing therapeutic animal Moreover, transcriptomics metabolism analyses revealed that mitigated inflammation suppressing production pro-inflammatory cytokines chemokines restoring lipid metabolism. Additionally, this nanomedicine modulated microbiota inhibiting pathogenic Proteus Escherichia-Shigella promoting proliferation beneficial probiotics, including Lachnoclostridium, Lachnospiraceae_NK4A136_group norank_f_Ruminococcaceae. Overall, our findings highlight potential butyrate-functionalized polymethacrylates versatile effective nanoplatforms repair combating IBD other gastrointestinal disorders.
Язык: Английский
Процитировано
45Journal of Controlled Release, Год журнала: 2023, Номер 362, С. 548 - 564
Опубликована: Сен. 9, 2023
Язык: Английский
Процитировано
32Bioactive Materials, Год журнала: 2023, Номер 33, С. 71 - 84
Опубликована: Ноя. 9, 2023
Inflammatory bowel disease (IBD) is a chronic and refractory condition characterized by disrupted epithelial barrier, dysregulated immune balance, altered gut microbiota. Nano-enabled interventions for restoring homeostasis have the potential to alleviate inflammation in IBD. Herein, we developed combination of olsalazine (Olsa)-based nanoneedles microbiota-regulating inulin gel reshape intestinal relieve inflammation. The Olsa-derived exhibited reactive oxygen species scavenging ability anti-inflammatory effects lipopolysaccharide-simulated macrophages. composite (Cu2(Olsa)/Gel) displayed macroporous structure, improved bio-adhesion, enhanced colon retention after oral administration. Mechanistically, effectively downregulated pro-inflammatory cytokine levels promoted barrier repair through antioxidant therapies, resulting significant alleviation colitis three animal models Furthermore, analysis microbiota revealed that Cu2(Olsa)/Gel treatment increased diversity microflora decreased relative abundance pathogenic bacteria such as Proteobacteria. Overall, this study provides self-delivering nanodrug dietary fiber hydrogel IBD therapy, offering an efficient approach restore homeostasis.
Язык: Английский
Процитировано
28International Journal of Biological Macromolecules, Год журнала: 2023, Номер 254, С. 127761 - 127761
Опубликована: Окт. 30, 2023
Язык: Английский
Процитировано
27International Journal of Biological Macromolecules, Год журнала: 2023, Номер 249, С. 125911 - 125911
Опубликована: Июль 28, 2023
Язык: Английский
Процитировано
23ACS Applied Materials & Interfaces, Год журнала: 2024, Номер 16(35), С. 46090 - 46101
Опубликована: Авг. 22, 2024
Epigallocatechin gallate (EGCG)-based nanosystems have garnered significant attention for their ability to alleviate inflammation due excellent anti-inflammatory properties and enhanced drug delivery capabilities. However, the degradation of EGCG in strongly acidic environments poses a challenge potential administration, particularly oral formulations, where gastric resistance is essential. In this study, we develop "disintegration reorganization" strategy create acid-resistant antioxidant nanoparticles (EGA NPs) based on 5-aminosalicylic acid (5-ASA) mitigating colitis acute kidney injury. At pH, ester bond breaks down, producing two building blocks. These, together with 5-ASA formaldehyde, form oligomers through combination phenol–aldehyde condensation Mannich reaction. The resulting self-assemble into EGA NPs, which exhibit stability under both neutral pH conditions. This makes them suitable allowing withstand harsh conditions, as well intravenous injection. Importantly, these retain EGCG, effectively scavenging reactive oxygen species reducing intracellular oxidative stress. Additionally, shows carrier, efficiently loading agent curcumin (Cur) Cur@EGA NPs. vivo studies demonstrate efficacy alleviating injury following respectively. These nanoparticulate formulations superior reduction compared free Cur vivo. Overall, our findings introduce novel nanoplatform treatment inflammation.
Язык: Английский
Процитировано
12ACS Applied Materials & Interfaces, Год журнала: 2024, Номер 16(6), С. 7686 - 7699
Опубликована: Янв. 30, 2024
The pathogenesis of ulcerative colitis (UC) is associated with the shedding gut mucus. Herein, inspired by biological functions mucus, growth factors-loaded in situ hydrogel (PHE-EK) was designed for UC treatment integrating dihydrocaffeic acid-modified poloxamer as a thermosensitive material hyaluronic acid (colitis-specific adhesive), epigallocatechin-3-gallate (antibacterial agent), and bioactive factors (KPV tripeptide epidermal factor). PHE-EK presented good properties, flowable liquid at room temperature gelled within 10 s when exposed to body temperature. mechanical strength strain 77.8%. Moreover, displayed antibacterial activity against Escherichia coli. Importantly, vitro vivo adhesive tests showed that could specifically adhere inflamed colon via electrostatic interaction. When biomimetic mucus rectally administrated rats, it effectively hindered weight loss, reduced disease index improved colonic shorting. expression pro-inflammatory cytokines (e.g., IL-1β, IL-6, TNF-α) laminae propria or epitheliums rats substantially inhibited PHE-EK. Besides, were well rearranged, tight junction proteins (Zonula-1 Claudin-5) between them greatly upregulated after treatment. Collectively, might be promising therapy UC.
Язык: Английский
Процитировано
9Biomacromolecules, Год журнала: 2023, Номер 24(5), С. 2250 - 2263
Опубликована: Апрель 17, 2023
The pathogenesis of inflammatory bowel diseases (IBDs) including ulcerative colitis (UC) and Crohn's disease is extremely cloudy. Maintaining the level remission lesions in default treatment attitude at present. Epithelial barrier restoration considered as same important strategy colonic targeted drug delivery UC treatment. In this paper, we developed a multilayer natural polysaccharide microsphere (pectin/chitosan/alginate) with pH enzyme dual sensitivity to reduce loss medication upper digestive tract preferentially adhere exposed epithelial cells tissues by electrostatic forces for efficiently Olsalazine an was loaded chitosan layer realized pH-responsive release. Furthermore, microspheres exhibited excellent capability suppressing harmful flora bio-adhesion effect extend duration local medicine. vivo anti-colitis study, downregulated levels pro-inflammatory factors increase tight junction protein indicated anti-inflammation olsalazine-loaded microspheres. summary, these results showed that could be powerful candidate system therapy.
Язык: Английский
Процитировано
20International Journal of Pharmaceutics, Год журнала: 2023, Номер 639, С. 122962 - 122962
Опубликована: Апрель 15, 2023
Язык: Английский
Процитировано
19Food and Bioprocess Technology, Год журнала: 2024, Номер unknown
Опубликована: Май 30, 2024
Язык: Английский
Процитировано
7